Kadimastem Overview
- Year Founded
-
2009
- Status
-
Public
- Employees
-
12
- Stock Symbol
-
KDST
- Share Price
-
$3.52
- (As of Thursday Closing)
Kadimastem General Information
Description
Kadimastem Ltd is a biopharmaceutical company that develops industrial regenerative medicine therapies based on differentiated cells derived from Human Embryonic Stem Cells (hESCs) to treat neuro-degenerative diseases such as ALS and Diabetes. It is developing revolutionary regenerative therapies based on stem cells.
Contact Information
Website
www.kadimastem.comCorporate Office
- Pinchas Sapir 7, Weizmann Science Park
- Ness Ziona 7414003
- Israel
Corporate Office
- Pinchas Sapir 7, Weizmann Science Park
- Ness Ziona 7414003
- Israel
Kadimastem Timeline
Kadimastem Stock Performance
As of 05-Dec-2024, Kadimastem’s stock price is $3.52. Its current market cap is $14.8M with 4.19M shares.
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $3.52 | $3.48 | $1.10 - $3.79 | $14.8M | 4.19M | 30.4K | -$0.73 |
Kadimastem Financials Summary
As of 30-Jun-2024, Kadimastem has a trailing 12-month revenue of null.
|
In Thousands, USD |
TTM 30-Jun-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 | FY 2021 31-Dec-2021 |
|---|---|---|---|---|
| EV | 5,933 | 6,384 | 9,527 | 37,913 |
| Revenue | 0 | 0 | 0 | 0 |
| EBITDA | (1,578) | (2,608) | (6,160) | (7,537) |
| Net Income | (2,571) | (3,241) | (6,755) | (8,113) |
| Total Assets | 1,426 | 2,204 | 3,544 | 8,799 |
| Total Debt | 1,955 | 1,666 | 2,024 | 1,914 |
Kadimastem Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Kadimastem Comparisons
Industry
Financing
Details
Kadimastem Competitors (47)
One of Kadimastem’s 47 competitors is Abeona Therapeutics, a Corporation company based in Cleveland, OH.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Abeona Therapeutics | Corporation | Cleveland, OH | ||||
| Lisata Therapeutics | Corporate Backed or Acquired | Basking Ridge, NJ | ||||
| Capricor Therapeutics | Formerly VC-backed | San Diego, CA | ||||
| ProMIS Neurosciences | Corporation | Toronto, Canada | ||||
| Dyne Therapeutics | Formerly VC-backed | Waltham, MA |
Kadimastem Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Kadimastem Patents
Kadimastem Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20220387514-A1 | Methods of treating acute respiratory distress syndrome | Inactive | 02-Jun-2021 | ||
| EP-3384286-A1 | Methods for differentiating and purifying pancreatic endocrine cells | Active | 30-Nov-2015 | ||
| EP-3384286-B1 | Methods for differentiating and purifying pancreatic endocrine cells | Active | 30-Nov-2015 | ||
| EP-3384286-A4 | Methods for differentiating and purifying pancreatic endocrine cells | Active | 30-Nov-2015 | ||
| US-20180369290-A1 | Methods for differentiating and purifying pancreatic endocrine cells | Active | 30-Nov-2015 | A61K35/39 |
Kadimastem Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Kadimastem Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Kadimastem ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Biotechnology
Subindustry
Rank
Percentile
Kadimastem FAQs
-
When was Kadimastem founded?
Kadimastem was founded in 2009.
-
Where is Kadimastem headquartered?
Kadimastem is headquartered in Ness Ziona, Israel.
-
What is the size of Kadimastem?
Kadimastem has 12 total employees.
-
What industry is Kadimastem in?
Kadimastem’s primary industry is Biotechnology.
-
Is Kadimastem a private or public company?
Kadimastem is a Public company.
-
What is Kadimastem’s stock symbol?
The ticker symbol for Kadimastem is KDST.
-
What is the current stock price of Kadimastem?
As of 05-Dec-2024 the stock price of Kadimastem is $3.52.
-
What is the current market cap of Kadimastem?
The current market capitalization of Kadimastem is $14.8M.
-
Who are Kadimastem’s competitors?
Abeona Therapeutics, Lisata Therapeutics, Capricor Therapeutics, ProMIS Neurosciences, and Dyne Therapeutics are some of the 47 competitors of Kadimastem.
-
What is Kadimastem’s annual earnings per share (EPS)?
Kadimastem’s EPS for 12 months was -$0.73.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
